Cutaneous neoplasia following PUVA therapy for psoriasis

British Journal of Dermatology

Volumn 134, Issue 4, 1996, Pages 639-642

  Mckenna, K E ^a,c   Patterson, C C ^b   Handley, J ^a   Mcginn, S ^a   Allen, G ^a  

^a BELFAST CITY HOSPITAL   (United Kingdom)

^b QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^c CRAIGAVON AREA HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

METHOXSALEN; PSORALEN;

ADULT; AGED; ARTICLE; BASAL CELL CARCINOMA; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PSORIASIS; SKIN TUMOR; SQUAMOUS CELL CARCINOMA; ULTRAVIOLET A RADIATION;

EID: 0029879904     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.1996.tb06962.x     Document Type: Article

References (28)

1. Parrish JA, Fitzpatrick TB, Tanebaum L, Pathak MA. Photochemotherapy of psoriasis with oral methoxsalen and long wave ultraviolet light. N Engl J Med 1974; 291: 1207-11.
2. Stern RS, Thibodeau LA, Kleinerman RA et al. Risk of cutaneous carcinoma in patients treated with oral methoxalen photochemotherapy for psoriasis. N Engl J Med 1979; 300: 800-13.
3. Stern RS, Lange R. Non-melanoma skin cancer occurring in patients treated with PUVA five to ten years after first treatment. J Invest Dermatol 1988; 91: 120-4.
4. Stern RS. Genital tumours among men with psoriasis exposed to psoralens and ultraviolet-A radiation (PUVA) and ultraviolet B radiation. N Engl J Med 1990; 322: 1093-7.
5. Chuang T-Y, Heinrich LA, Schultz MD et al. PUVA and skin cancer. J Am Acad Dermatol 1992; 26: 173-7.
6. Honigsmann H, Wolff K. Gschnait F et al. Keratoses and non-melanoma skin tumors in long-term photochemotherapy (PUVA). J Am Acad Dermatol 1980; 3: 406-14.
7. Lassus A, Reunala T, Idanpaa-Heikkila J et al. PUVA treatment and skin cancer: a follow-up study. Acta Derm Venereol (Stockh) 1981; 61: 141-5.
8. Eskelinen A, Halme K, Lassus A et al. Risk of cutaneous carcinoma in psoriatic patients treated with PUVA. Photodermatology 1985; 2: 10-14.
9. Henseler T, Christophers K, Honigsmann H et al. Skin tumors in the European PUVA study. J Am Acad Dermatol 1987; 16: 108-16.
10. Bruynzeel I, Bergman W, Hartevelt HM et al. 'High single-dose' European PUVA regimen also causes an excess of non-melanoma skin cancer. Br J Dermatol 1991; 124: 49-55.
11. Lindelof B, Sigurgeirsson B, Tegner E et al. PUVA and cancer: a large-scale epidemiological study. Lancet 1991; 338: 91-3.
12. Muir C. Waterhouse J, Mack T et al. (eds) Cancer Incidence in Five Continents. Vol. 5. IARC Scientific Pub. No. 88, Lyon 1987.
13. Ko CB, Walton S, Keczkes K, et al. The emerging epidemic of skin cancer. Br J Dermatol 1994; 130: 269-72.
14. Roberts DL. Incidence of non-melanoma skin cancer in West Glamorgan, South Wales. Br J Dermatol 1990; 122: 399-403.
15. Beadle PC, Bullock D, Bedford G et al. Accuracy of skin cancer incidence data in the United Kingdom. Clin Exp Dermatol 1982; 7: 255-60.
16. Pathak MA, Kitzpatrick TB, Parrish JA. Pharmacologic and molecular aspects of psoralen photochemotherapy. In: Psoriasis: Proceedings of the Second International Symposium (Farber EM, Cox AJ, eds). New York: Yorke Medical Books. 1977.
17. Bridges BA. Possible long-term hazards of photochemotherapy with psoralens and near ultraviolet light. Clin Exp Dermatol 1978; 3: 349-53.
18. Young AR, Magnus IA, Davies AC, Smith NP. A comparison of the phototumorigenic potential of 8-MOP and 5-MOP in hairless albino mice exposed to solar simulated radiation. Br J Dermatol 1983; 108: 507-18.
19. Ree K. Reduction of Langerhans cells in human epidermis during PUVA therapy: a morphometric study. J Envist Dermatol 1982; 78: 488-92.
20. Morison WL, Parrish JA, Bloch KJ, Krugler JL. In vivo effects of PUVA on lymphocyte function. Br J Dermatol 1981; 104:405-13.
21. Gibbs NK, Honigsmann H, Young AR. PUVA treatment strategies and cancer risk. Lancet 1986; i: 150-1.
22. Reshad H, Challoner F, Pollock DJ et al. Cutaneous carcinoma in psoriatic patients treated with PUVA. Br J Dermatol 1984; 110: 299-305.
23. Cox NH, Jones SK, Downey DJ et al. Cutaneous and ocular side-effects of oral photochemotherapy: results of an 8-year follow-up study. Br J Dermatol 1987; 116: 145-52.
24. Abdullah AN, Keczkes K. Cutaneous and ocular side-effects of PUVA photochemotherapy - a 10-year follow-up study. Clin Exp Dermatol 1989; 14: 421-4.
25. Perkins W, Lamont D, MacKie RM. Cutaneous malignancy in males treated with photochemotherapy. Lancet 1990; 336: 1248.
26. Lever LR, Farr PM. Skin cancers or premalignant lesions occur in half of high-dose PUVA patients. Br J Dermatol 1994; 131: 215-19.
27. Forman AB, Roenigk HH, Caro WA, Magid ML. Long-term follow-up of skin cancer in the PUVA-48 cooperative study. Arch Dermatol 1989; 125: 515-19.
28. Gallagher RP, Hill CB, Bajdik CD et al. Sunlight exposure, pigmentary factors, and risk of nonmelanocytic skin cancer. I. Basal cell carcinoma. Arch Dermatol 1995; 131: 157-63.